Protein phosphatase 1 in tumorigenesis: is it worth a closer look?

Biochim Biophys Acta Rev Cancer

Laboratory of Signal Transduction, Department of Medical Sciences, Institute of Biomedicine - iBiMED, University of Aveiro, 3810-193, Aveiro, Portugal. Electronic address:

Published: December 2020

AI Article Synopsis

  • Cancer cells utilize signaling pathways to support their growth and survival, relying on reversible protein phosphorylation regulated by protein kinases and phosphatases.
  • Imbalances in these phosphorylation processes are linked to cancer development and progression.
  • This paper highlights the critical yet underappreciated role of Protein Phosphatase 1 (PP1) in tumor development, presenting strong evidence of its involvement in cancer biology.

Article Abstract

Cancer cells take advantage of signaling cascades to meet their requirements for sustained growth and survival. Cell signaling is tightly controlled by reversible protein phosphorylation mechanisms, which require the counterbalanced action of protein kinases and protein phosphatases. Imbalances on this system are associated with cancer development and progression. Protein phosphatase 1 (PP1) is one of the most relevant protein phosphatases in eukaryotic cells. Despite the widely recognized involvement of PP1 in key biological processes, both in health and disease, its relevance in cancer has been largely neglected. Here, we provide compelling evidence that support major roles for PP1 in tumorigenesis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2020.188433DOI Listing

Publication Analysis

Top Keywords

protein phosphatase
8
protein phosphatases
8
protein
6
phosphatase tumorigenesis
4
tumorigenesis worth
4
worth closer
4
closer look?
4
look? cancer
4
cancer cells
4
cells advantage
4

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Beckman Coulter Inc., Chaska, MN, USA.

Background: The analytical performance characteristics for the plasma Glial Fibrillary Acidic Protein (GFAP) immunoassay currently under development on Beckman Coulter, Inc. Access2™ and DxI9000™ analyzers is described. Blood GFAP levels may be indicative of the extent of neurologic injury in diseases such as TBI and stroke and maybe used as a marker of disease progression in other diseases such as multiple sclerosis.

View Article and Find Full Text PDF

Background: Synaptic dysfunction is a central pathologic feature of Alzheimer's disease (AD), with synaptic loss even preceding neuronal loss in specific brain regions. In healthy individuals, synaptic function and plasticity are orchestrated through the complex integration of signaling inputs generated by cell surface receptors.

Methods: In this study, we investigate the role of one such receptor, protein tyrosine phosphatase receptor sigma (PTPRS), in the context of Alzheimer's disease.

View Article and Find Full Text PDF

Background: Mild cognitive impairment may increase the risk of Alzheimer's disease (AD) or probably accelerate the progression. AD is the most common cause of dementia, substantial neuronal loss, and neuropathological lesions can damage many brain regions. Symptoms of the disease begin with mild memory difficulties and evolve towards cognitive impairment.

View Article and Find Full Text PDF

Background: Regional distribution of neurofibrillary tangles consisting of hyperphosphorylated tau correlates strongly with the progression of Alzheimer's disease (AD). Misfolded proteopathic tau templates the conversion of naive tau into a pathological state in a prion-like fashion, which underlies the spreading of tau pathology in the brain. Whether hyperphosphorylation triggers tau aggregation or hyperphosphorylation occurs after aggregation is under much debate.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

University of Kentucky College of Medicine, Sanders-Brown Center on Aging, Lexington, KY, USA.

Background: Our lab recently developed 2 mouse monoclonal antibodies that preferentially react with "distressed astrocytes". One monoclonal, 26A6, was found to react preferentially with a form of the Ca2+/calmodulin-dependent protein phosphatase, calcineurin (CN), that has been cleaved by calpain, to generate a 48 kDa CN fragment (∆CN). We recently published a characterization of this antibody.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!